Skip to main content
. Author manuscript; available in PMC: 2023 Mar 17.
Published in final edited form as: Lancet Haematol. 2018 Dec;5(12):e618–e627. doi: 10.1016/S2352-3026(18)30176-5

Figure 1: Trial profile.

Figure 1:

CVAD=cyclophosphamide, vincristine, doxorubicin, and dexamethasone.

*Health insurance coverage was not an exclusion criteria per se, but was necessary for patients to be enrolled on any clinical trial with coverage to receive the therapy.